Loading insider details...
Beta
Latest Form 4 (Mar 9, 2026): Grant/Award of 744,960 PMVP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 9, 2026 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 744,960 | n/a |
| Oct 29, 2025 | PMV Pharmaceuticals, Inc. (PMVP) | Exercise/Conversion | 220,643 | $302.3K |
| Jul 3, 2025 | PMV Pharmaceuticals, Inc. (PMVP) | Sale | 58,411 | $62.2K |
| Mar 5, 2025 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 800,000 | n/a |
| Jan 22, 2025 | PMV Pharmaceuticals, Inc. (PMVP) | Exercise/Conversion | 91,750 | $48.6K |
| Oct 3, 2024 | PMV Pharmaceuticals, Inc. (PMVP) | Disposition to Issuer | 134,584 | n/a |
| Jan 22, 2024 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 163,890 | n/a |
| Nov 13, 2023 | PMV Pharmaceuticals, Inc. (PMVP) | Exercise/Conversion | 198,407 | $105.2K |
| Aug 8, 2023 | PMV Pharmaceuticals, Inc. (PMVP) | Exercise/Conversion | 85,500 | $45.3K |
| May 15, 2023 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 330,000 | n/a |